The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Enliven Therapeutics Inc’s current trading price is -24.83% away from its 52-week high, while its distance from the 52-week low is 69.74%. The stock’s price range for this period has been between $13.30 and $30.03 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.33 million for the day, a number notably higher than the average daily volume of 0.35 million over the last three months.
Enliven Therapeutics Inc experienced a somewhat steady performance in the stock market.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Enliven Therapeutics Inc (ELVN) has experienced a quarterly rise of 8.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.11B and boasts a workforce of 62 employees.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ELVN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
ELVN Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 0.33% this year. Over the last six months, there has been a stronger performance of -5.11%. The price of ELVN fallen by 13.50% during the last 30 days period. For the last 5-days stocks have improved 8.85%.
